𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of eicosanoids and NSAIDs as PPARγ ligands in colorectal carcinoma cells

✍ Scribed by J.B. Nixon; H. Kamitani; S.J. Baek; T.E. Eling

Book ID
117641824
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
278 KB
Volume
68
Category
Article
ISSN
0952-3278

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PPARγ inhibitors reduce tubulin protein
PPARγ inhibitors reduce tubulin protein levels by a PPARγ, PPARδ and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells
✍ Katherine L. Schaefer; Hirokazu Takahashi; Victor M. Morales; Gianni Harris; Sus 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 827 KB

## Abstract The nuclear transcription factor peroxisome proliferator‐activated receptor‐gamma (PPARγ) has been identified as an important therapeutic target in murine models of colorectal cancer (CRC). To examine whether PPARγ inhibition has therapeutic effects in late‐stage CRC, the effects of PPA

PPARγ ligands suppress proliferation of
PPARγ ligands suppress proliferation of human urothelial basal cells in vitro
✍ Satoru Kawakami; Gaku Arai; Tetsuo Hayashi; Yasuhisa Fujii; Guangbin Xia; Yukio 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 406 KB

Expression of peroxisome proliferator-activated receptor (PPAR) gamma in the human urinary tract through embryonic development suggests its possible roles in the development, proliferation, and differentiation of uroepithelium. Little is known, however, about physiological roles of PPARgamma in the